Objectives: Array-comparative genomic hybridization (aCGH) is ahigh-throughput method to detect and map copynumberaberrations in thegenome.Multi-step analysis of high-dimensional datarequiresanintegratedsuite of bioinformatic tools. In this paper we detailananalysis pipelinefor array CGHdata. Methods: We developedananalysis tool forarray CGH data which supports single andmulti-chip analyses as wellascombined analyseswithpaired mRNA gene expression data. Thefunctionssupportingrelevantsteps of analysis wereimplemented usingthe opensource softwareRand combinedaspackage aCGHPipeline. Analysis methods wereillustrated using189 CGH arrays of aggressive B-celllymphomas. Results: The package covers data input, quality control, normalization,segmentation andclassification.For multi-chip analysis aCGHPipelineoffersanalgorithm forautomatic delineation of recurrent regions. This task wasperformedmanuallyuptonow.The package also supports combinedanalysis with mRNA gene expression data. Outputs consist of HTMLdocuments to facilitate communicationwithclinicalpartners. Conclusions: The Rpackage aCGHPipelinesupports basic tasks of single andmulti-chip analysis of array CGHdata.
Introduction
Aberrations in copy number playanimportant role in various diseases, especially in the pathogenesiso fm alignantt umors [ 1] . Thelength of aberrant segments can range from af ew base-pairs to whole chromosomes. Copy number aberrations can affect gene expression: Deletions mayl ead to tumors uppressorg enei nactivation and copy number gains maycause activation of oncogenes [2] .
Arrayc omparative genomich ybridization (aCGH) is am ethod to detecta nd map thesec opyn umber aberrations in the genome.S everal thousandk nown DNA clonesoroligonucleotidesare spotted on a chip [1] . Each clone representsaspecificregion of the genome. Resolutionand coverageofthe analysis depends on the number of spotted clonesa nd their distribution in the genome.
DNAisisolatedfrom test and reference tissuea nd differentially labeledu sing fluorescence dyes. Ab alanced mixture of labeled testand referenceDNA is hybridized to the CGH array.
Test and referenceDNA compete forfree binding sites [ 3] . Signals of testa nd reference fluorescence intensity at each clone position aremeasured, preprocessed [4] and combined as alog2ratio. This signalisassumedproportionaltothe log2 ratiooftest andr eference copy number in the corresponding genomicregion.Ifthe reference tissuei sc hosen euploid, information on copy number changesinthe testsample can be obtained. Rawdatafrom one CGH-array experiment consists of severalt housand clone-specificlog2ratios.
Motivation
Due to data complexity,manualinterpretation of arrayC GH datai st ime-consuming anderror-prone. Automatic methods which facilitate the arrayC GH analysisa re required.
We developed an analysis tool for array CGH data [5] whichs upports single and multi-chip analysis as well as combined analysis with paired mRNA gene expression data. Themethods were implementedusing the opens ources oftware R [ 6] andc ombined as packageaCGHPipeline.The packagei sa vailableu pon request.M osto ft he currentlya vailablea nalysisp rogramsa re limited in the capability of multiple-chip analysis. Forexample, CGH-Plotter [7] and CGHPro [8] provide onlyagraphicalcomparisonofdifferent chips butthere is no supportf or further statistical investigationso f geneticdifferences. Theaim of aCGHPipeline is to overcome these limitations.
Herew ed escribe relevant steps in the analysis of arrayCGH datathatcan be performedusing functions from our tool.F igure1givesaschematic overviewovertasks addressed belowwhich aresupported by the package. Illustrations aret aken from an analysis of arrayC GH datao f1 89 aggressive B-cell lymphomas [9] . Each arraycontained2799 BAC/PACclones. 1500 of these clonescover the whole genome at intervals of approximately2Mb, the remaining 1299 clonesspanregionsknown to be frequently involved in B-cell neoplasmso rc ontain proto-oncogenes or tumor suppressorgenes [9] .
Methods

3.1Q ualityControl
As for otherh igh-throughput methods a quality control step is requiredtodetect and reject invalid data.For everychip andevery clone aCGHPipeline calculatesthe median absolute deviation andt he proportion of missing values. Summary statistics, histogramsand listsofarraysand clonesw hich ares uspicious ares ummarized in au serfriendlyH TMLo utput file forf urther inspection.
Large-scalec opyn umber polymorphisms also occurasnaturalvariation of the normal human genome. Thelength of polymorphic segments rangesf rom kilo-to megabases [10] . To distinguish between normal variation andc ancer-specifica berrations,i ti si mportantt oc ompare the genomicp ositions of the used clone probes with knownp olymorphic sites. Therefore everyc loneo nt he arrayi sc omparedw ith the "Database of GenomicV ariants" (http://projects.tcag.ca/variation/) [11] . Clonesw hich arel ocated in regions with knownc opyn umber polymorphisms are marked,e nabling the user to interprett he measuredvaluescautiously.
3.2N ormalization
Imbalances in the amount or quality of used test and referenceD NA mayl ead to systematic array-specificbiasinthe measured log2 ratios.Differences in labeling efficiencies of the fluorescence dyes maybeeliminatedbyusing adye swap design [12] . The aimo fn ormalization is to remove chipspecific bias. aCGHPipeline provides aglobalnormalization for the correction of array CGH data: Assuming thatt he majority of clone positions is euploidi nb oth tissues mosto ft he log2 ratios should vary about zero.Thus,ameasure of location,likemean, medianormode,can be used to estimate the biasindividuallyfor each array. Thebiasis thenremoved by subtracting the measure of location froma ll measurements on this array. We take the 50%ofthe measurements with the highest valuesinthe corresponding densityf unction andc alculate the mean of thesev aluesw eighted with the appropriate densityasanestimator forthe mode of the distribution.Wesuggest using thismode estimator fornormalization, because based on asimulation study it is morerobustincases with ar elevantp roportion of aberrant clones.
3.3S egmentation
Thegoalofarray CGH analysis is the detection of copy number aberrations in tumor DNA. Measured signals have to be classified in chromosomalg ains,l osses and regions with normal copy number.C opy numbers cannot be directly read offthe signalratios:The signaltonoise ratioisrather low [13] andsamples of primarytumorsare typically contaminatedw ith ac ertain amount of non-tumor DNAthus attenuating the ratio. As trategy forn oise reduction is needed.
Copynumber aberrations typically occur in segments comprising severalclones. Segmentation methods aima td etecting segments of neighboring cloneswith the same copy number andtosmooth the signaltoreducethe noise.
Severals egmentation algorithmsf or arrayCGH dataare describedinthe literature [2, 7, [14] [15] [16] [17] [18] [19] . We have implementedan interface to the Hidden Markov Model (HMM)-based segmentation method of Fridlyand et al. [ 17] andt ot he Circular BinaryS egmentation (CBS)m ethod of Olshenetal. [16] .Based on the results from other research groups [20, 21] , andf ollowing our owne xperience, we currently recommend using the CBS methodo f Olshen.
Fig. 1
Stepsofanalysis in array CGHdata
3.4C lassification
Afters egmentation each arrayi sr epresented by as et of segments ands moothed segment-specifics ignals. To ease interpretation the segments arec lassified into gains,l osses and segments with normal copy number.N ote that with currentt echnology further differentiation within the lossorgaincategoryisdifficult exceptfor high-levela mplification peaks. Thresholds arerequired to achieve such asubdivision. If as egment leveli sa bove the threshold,t he segment is classified as ag ain. As egment whichi sb elow minust he threshold is counted as al oss. This process is also referred to as threshholding. aCGHPipeline supports choosing af ixed or an oise-dependent threshold. Afixed threshold is uniformlyspecified on the log2 ratioscalefor alla rrays. An oise-dependent threshold is specifiedinunitsofanarray-specificnoise estimate.F or each arraya CGHPipeline providesar obustn oise estimator based on medianabsolutedeviation of the differences between measuredl og2r atios andt he corresponding smoothed segment levels.Thus the noise estimate is noti nflated by genetich eterogeneity.C hoosing the noisedependent approach leadst oa ni ncreased threshold for chips with poor quality butnot for chips with ahigh genetic heterogeneity.
Users have to specifyt he classification threshold manuallyc onsidering information on the fraction of normal tissuec ontamination in tumor samples andthe sensitivity of the arrayt ype used.F or ag iven arrayp latform the sensitivity can be assessed on the basisofdatawith knowncopy number aberrations or through the analysis of DNAwith different numbers of Xchromosomes [13, 22] .
An example of classified arrayC GH datai ss hown in Figure 2 . Afterc lassification the genetic heterogeneity of each arraycan be summarized,e.g.bycalculating the numbero fa berrants egments or clones. These heterogeneitymeasureshelp to quantify the instability of the genome in different tumore ntities or to analyzet he impact of heterogeneityo nt he prognosis of patients.
3.5M ulti-chipAnalysis
When analyzing al arge set of tumor samples amajor biological question is to detect regions whicha re commonly aberrant andtherefore mayb ek ey events fortumor development or proliferation.
Amajor objective of multi-chip analysis is thus to delineategenomicregionsw hich arec haracteristically aberrant in as pecific typeofcancer.These recurrentregionsprovide lists of putative candidate genesf or biological follow-up research.P resence or absence of recurrentr egionsi ns ingle tissues define candidate variables for prognostic factor analyses.
Up to nowt hese recurrentr egionsw ere visuallydeterminede.g.bylooking at heatmaps (Fig. 3b) . We developed an algorithm to automatically propose recurrentregions. We firstc alculate andp lot the frequencies of gains andlosses for each clone along the genome (seeF ig. 3a forasingle chromosome). To delineater ecurrentr egionsa s "genomicr egionsw hich arec haracteristically aberrant in the data"wedivide clones into segments with the samef requencyo f aberration andd efine recurrentr egionsa s those resulting segments that areboth above ac ertain threshold andd ominate adjacent segments.
3.5.1S egmentationofMultiple-chip Frequency Data
Forsegmentation we useaHidden Markov Model( HMM) [23] . Each stateh as ab inomiale mission distribution with varying underlyingprobabilityp.HMMs with up to five states are fittedc hromosome-wise to the frequencies of gains andl osses of the clonesb ecause the numbero fr ecurrence levels is initiallyu nknown. Themodelt hat fits best is selected via the Akaikeinformation criterion(AIC).Smoothingisachieved through astate transition matrix givinghigh probability to staying in the sameu nderlying state. Ther esult of the segmentation procedure for gains andlosses is illustrated in Figure 3a . 
3.5.2T hresholdfor Recurrence
As an exts tepw eh avet os eparate" characteristic"s egments froms poradic ones. Everysegment is therefore comparedwith a frequencyt hreshold. Regions whichs how an aberration more frequentlyt hant he selected threshold were counted as recurrent segments.R ecurrents egments thatd ominate neighboring segments ares elected as recurrentregions.
Theuser can specifyafrequencythreshold or useat hreshold that is suggested by our algorithm.a CGHPipeline uses a 2-meansc lusteringo ft he frequencies of gains andlosses of the clonestodistinguish sporadic formc haracteristic aberrations. Them ean of the centero ft he "sporadic aberrations"a nd the centero ft he "characteristic aberrations "centers is used as the threshold.
Automaticallyd elineated recurrentr egions should be checked manually by inspecting ah eatmapb ecause theoretically the identity of the cases contributing to arecurrentregion mayvaryalongthe segment indicating thatthe region should be split.
3.5.3A nalysis of Recurrent Regions
Having delineated the recurrentr egionsi n the data set one maywanttodecide on presence or absence of recurrentr egionsi n single samples.Wehaveimplementedavoting algorithm for thispurpose. Arecurrent region consists of as et of clones. Ar ecurrent region is calledpresent in an individual sample if ando nlyi fauser-specified proportion (e.g.50%) of itscloneset is classified as concordant aberration.
The algorithm determinesam atrix of CGHarraysbyrecurrentregionsindicating presence and absence of the recurrentr egions on the respective chip. The horizontal blue barinFigure 3b indicates the result of the voting algorithm for the recurrentregion marked by the vertical grey bar.
3.6A nalysisofPaired ArrayCGH and Gene ExpressionData
If paireda rray CGH andg enee xpression data is availableo ne can ask whetherare- spective aberration is associated with agene dosee ffect on mRNAg enee xpression. Giventhe assignment of copy number aberrations in recurrentr egionst oi ndividual samples as describeda bove,m RNAe xpression in samples with the aberration can be comparedt os amples without thisa berration. Figure 4depicts confidenceintervals for the differencei nm ean gene expression comparingcases with andwithout alossfor genesm apping intoarecurrentr egion on chromosome 6inlymphomadata.
If ah igher resolutioni sd esired, am apping assigning copy number information from individual clonestogenes in the corresponding genomicregion is required.
We have implementedanalgorithmthat generates ad atap airf or each gene expression probe set consisting of the respective mRNA expression levela nd ac opy number stated erived from the arrayC GH data. If ap robe set maps on oneo rm ore CGHc lones their copy number statei sa ssignedifequivalent. If the probeset maps in agap between clonesonthe CGHarray the copy number stateofthe neighboring clones is returnedifequivalent. Otherwise amissing value is assigned.
Application
Theanalysispipeline wasapplied to aset of 189 arrays of aggressive B-cell lymphomas. Within the quality control step sixa rrays were rejected due to high noise.Inaddition 48 clonesw eree xcluded from the analysis because theyweremissing in morethan50 percento ft he cases. 291 of the remaining clonesa re located in regions with known copy number polymorphisms.
ArrayC GH dataw as normalizedu sing global normalization with mode estimator. Normalized log2 ratios were smoothed by applying the CircularBinary Segmentation (CBS)method of Olshenetal. with default parameters.
Forasubset of 106 arrays,manualinterpretation of the data wasavailable. Best concordanceb etween manual anda utomatic classification wasachievedbyusing afixed threshold of 0.17 for the classification of the segments resulting fromC BS.I nt hatc ase 96.8% of allc lones were assessed consistently.M ore than 83% of the clones whichwerecalledaberrantbymanualinterpretation were concordantlydetected by the automatic method. Investigation of discrepantr esults showed thati nc ases where one method assignedacopy number gain while the other assignedalossmostlyrepresented sign errors within the manual analysis. Theb ulk of discrepancies occurred at boundaries of aberrant regions andincases wheret he putative aberration is quantitatively weak.I nt hese casesav alidation of the results is difficult.
Using the methods formulti-chip analysis1 6r egionso fr ecurrentg ains ands ix regions of recurrentlosses were delineated for furtherinvestigation.
Conclusion and Outlook
With aCGHPipeline we developed ac omprehensivet ool for the analysis of array CGH data. Thep ackagec oversd atai nput, quality control, normalization, segmentation andc lassification.T he automatic analysis essentiallyr eproduced the manual interpretation. It is less error-prone,l ess time-consuming andm ore reproducible, thus further analyses of our group will be based on it.
Form ulti-chip analysis aCGHPipeline proposesanalgorithmfor automatic delineation of recurrentr egions. This task was performed manuallyuptonow.The package also supports combined analysis with mRNAg enee xpression data. Results are presented as HTML documents to facilitate communication with clinical partners. aCGHPipeline is implemented in Ri n whichf urther data analysis can easily be performed. Thec urrent version of the program provides no graphicaluser interface so thatu sers need ab asick nowledge of R programming.Aplannedi ntegration of aCGHPipeline in the gene expression warehouse(GeWare) [24] will addthis feature.
